Atherosclerosis

Clinical Trial Finder

Many patients with atherosclerosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial

Conditions:   Arteriosclerosis;   Coronary Artery Disease;   Myocardial Ischemia;   Coronary Disease
Interventions:   Procedure: CrossBoss Catheter;   Procedure: Antegrade Wire Escalation Strategy
Sponsors:   North Texas Veterans Healthcare System;   Henry Ford Hospital;   Massachusetts General Hospital;   Avera Sacred Heart Hospital;   United Heart and Vascular Clinic/United Hospital;   St. Boniface General Hospital Research Centre;   Deborah Heart and Lung Center;   Sutter Health;   Edward Hospital
Not yet recruiting - verified July 2015

Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)

Condition:   Critical Limb Ischemia (CLI)
Interventions:   Biological: CLBS12;   Drug: SOC
Sponsor:   Caladrius Biosciences, Inc.
Not yet recruiting - verified July 2015

The PaWS (Pedometer and Walking Study)

Condition:   Intermittent Claudication
Intervention:   Other: Pedometer
Sponsors:   University Health Network, Toronto;   St. Michael
Recruiting - verified July 2015

VEST III PMS Clinical Protocol

Condition:   Coronary Artery Disease
Interventions:   Device: VEST External Support;   Procedure: Coronary Artery Bypass Surgery
Sponsor:   Vascular Graft Solutions Ltd.
Not yet recruiting - verified July 2015

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center (CPC), Denver, Colorado, USA
Not yet recruiting - verified July 2015

Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment

Conditions:   Autoimmune Diseases;   Coronary Artery Disease
Intervention:  
Sponsors:   Semmelweis University Heart and Vascular Center;   University of Debrecen
Recruiting - verified July 2015

Prevalence of Chronic Kidney Disease and Its Association With Clinical Outcome in Patients With Coronary Heart Disease

Conditions:   Coronary Heart Disease;   Chronic Kidney Disease
Intervention:  
Sponsors:   Peking University First Hospital;   Pfizer
Not yet recruiting - verified July 2015

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents

Conditions:   Coronary Artery Disease;   Angina Pectoris;   Unstable Angina Pectoris;   Acute Coronary Syndrome;   Coronary Stenosis;   Coronary Restenosis
Interventions:   Device: Orsiro;   Device: Resolute Onyx
Sponsor:   Thorax Centrum Twente
Not yet recruiting - verified July 2015

Ivabradine and Post-revascularisation Microcirculatory Dysfunction

Conditions:   Coronary Artery Disease;   Angina
Intervention:   Drug: Ivabradine
Sponsor:   Liverpool Heart and Chest Hospital NHS Foundation Trust
Not yet recruiting - verified July 2015

OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation

Condition:   Coronary Artery Disease
Interventions:   Device: Sirolimus Eluting Stent Inspiron;   Device: Bare Metal Stent
Sponsor:   Scitech Produtos Medicos Ltda
Recruiting - verified July 2015

York Study of Unloading Shoes for Vascular Intermittent Claudication

Conditions:   Intermittent Claudication;   Peripheral Arterial Disease
Interventions:   Device: Unloading shoes;   Device: Unadapted control shoe
Sponsors:   York Teaching Hospitals NHS Foundation Trust;   University of York;   York St John University;   University of Salford
Not yet recruiting - verified July 2015

Stavanger UncomPlicatEd Elective PCI Same DaY Discharge Study (SPEEDY Study)

Condition:   Coronary Artery Disease
Intervention:   Procedure: same day discharge
Sponsor:   Helse Stavanger HF
Not yet recruiting - verified July 2015

CER-001 Atherosclerosis Regression ACS Trial

Condition:   Acute Coronary Syndromes
Interventions:   Drug: CER-001;   Drug: Placebo
Sponsors:   Cerenis Therapeutics, SA;   South Australian Health and Medical Research Institute
Not yet recruiting - verified July 2015

Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I)

Condition:   Coronary Artery Disease
Intervention:   Device: Fantom Scaffold
Sponsor:   REVA Medical, Inc.
Active, not recruiting - verified July 2015

Stroke Imaging Package Study

Conditions:   Atherosclerosis;   Stroke;   Infarction, Middle Cerebral Artery;   Vertebrobasilar Insufficiency;   Cerebral Small-vessel Disease;   Moyamoya Syndrome
Intervention:  
Sponsors:   Wei-Hai Xu;   Peking University First Hospital;   Peking Union Medical College Hospital;   General Hospital of Chinese Armed Police Forces;   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University;   General Hospital of Shenyang Military Region;   Subei People's Hospital of Jiangsu Province;   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Beijing Jishuitan Hospital;   Beijing Friendship Hospital;   Fuxing Hospital of Capital Medical University;   Fujian Medical University;   Jingan District Central Hospital of Shanghai (Jingan Branch of Huashan Hospital Affiliated to Fudan University);   First Hospital of Jilin University;   The First Affiliated Hospital of University of South China;   Qilu Hospital of Shandong University (Qingdao);   Tangshan Gongren Hospital;   Wuhan University;   Third Affiliated Hospital, Sun Yat-Sen University;   Renmin Hospital of Wuhan University;   Qilu Hospital;   Qingdao Municipal Hospital
Recruiting - verified July 2015

Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes

Condition:   Diabetes-related Complications
Intervention:   Drug: dobutamine
Sponsor:   University of Avignon
Recruiting - verified July 2015

The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery

Condition:   Coronary Artery Disease
Intervention:  
Sponsors:   HealthSpan Dx;   Duke University
Recruiting - verified July 2015

Physiotherapy Exercises in Patients With Sternal Instability After Cardiovascular Surgery

Conditions:   Mediastinitis;   Coronary Artery Disease;   Cardiovascular Infections
Intervention:   Other: physiotherapy exercises
Sponsors:   Emilia Nozawa, PT PhD;   University of Sao Paulo
Completed - verified July 2015

TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement: the TIRATROP Study

Condition:   Atherosclerosis
Interventions:   Drug: ticagrelor;   Drug: clopidogrel
Sponsor:   University Hospital, Toulouse
Not yet recruiting - verified July 2015

The Miami Heart Study at Baptist Health South Florida

Condition:   Cardiovascular Disease
Intervention:  
Sponsors:   Baptist Health South Florida;   Quest Diagnostics;   University of California, Los Angeles
Recruiting - verified July 2015

Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel

Condition:   Coronary Disease
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   Yongjian Wu
Recruiting - verified July 2015

Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI

Conditions:   Myocardial Ischemia;   Coronary Artery Disease;   Endothelial Dysfunction
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   University Hospital of Limerick
Recruiting - verified July 2015

Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography

Conditions:   Coronary Atherosclerosis;   Coronary Artery Disease;   Radiocontrast-induced Thyroid Dysfunction;   Contrast-induced Nephropathy
Interventions:   Radiation: Coronary computed tomography angiography;   Radiation: Quantitative coronary angiography
Sponsors:   Ural Medical University ;   Ural Institute of Cardiology;   De Haar Research Foundation
Enrolling by invitation - verified July 2015

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Conditions:   Ischemic Heart Disease;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Intervention:   Device: Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
Sponsor:   Medtronic Vascular
Active, not recruiting - verified July 2015

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Conditions:   Coronary Artery Disease;   Atherosclerosis, Coronary;   Myocardial Ischemia;   Ischemic Heart Disease;   Acute Coronary Syndrome;   Angina Pectoris
Interventions:   Device: Orsiro DES;   Device: Xience DES
Sponsors:   Biotronik, Inc.;   Biotronik AG;   Harvard Clinical Research Institute;   Medstar Research Institute
Recruiting - verified June 2015

MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions

Condition:   Coronary Artery Disease
Intervention:   Device: MAGIC-TOUCH Drug-eluting Balloon
Sponsor:   Scitech Produtos Medicos Ltda
Recruiting - verified July 2015

The Asahi Intecc PTCA Chronic Total Occlusion Study

Conditions:   Coronary Artery Disease;   Coronary Artery Chronic Total Occlusion
Intervention:   Device: Revascularization of Coronary Artery Chronic Total Occlusion (Corsair, Gaia, Asahi Guide Wires)
Sponsors:   Asahi Intecc USA Inc;   Medpace, Inc.
Recruiting - verified July 2015

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II

Condition:   Acute Coronary Artery Syndrome
Interventions:   Procedure: Percutaneous coronary intervention;   Procedure: Intravascular ultrasound with virtual histology;   Drug: Atorvastatin or other equivalent dose statin;   Device: LDL-apheresis
Sponsor:   Department of Veterans Affairs
Recruiting - verified July 2015

Effects of Limb Ischemic Postconditioning in Young sICAS

Condition:   Stroke
Intervention:   Device: Remote ischemic postconditioning
Sponsors:   Xi’an Jiaotong University College of Medicine;   Xuanwu Hospital, Beijing
Recruiting - verified July 2015

Clinical Study Protocol - Debris Interventional Removal in ACS (DESIRE-ACS)

Conditions:   Coronary Disease;   Acute Coronary Syndrome;   Coronary Occlusion
Intervention:   Device: Bell Balloon Catheter
Sponsor:   Angioslide Ltd.
Recruiting - verified July 2015

A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques

Conditions:   Arteriosclerosis;   Diabetes Mellitus;   Lipid Disorder
Interventions:   Drug: Rosuvastatin 5mg;   Drug: Rosuvastatin 20mg
Sponsor:   Capital Medical University
Recruiting - verified July 2015

The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis With Vulnerable Plaque Characteristics

Conditions:   Coronary Artery Disease;   Plaque, Atherosclerotic
Interventions:   Device: Bioresorbable Vascular Scaffold;   Drug: Optimal Medical treatment
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Not yet recruiting - verified July 2015

Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study

Condition:   Stroke, Acute
Intervention:  
Sponsors:   University of Zurich;   Swiss National Science Foundation
Recruiting - verified July 2015

Assessment of Coronary Flow Reserve by PET-H215O and FFR. Comparison With Dynamic Acquisition Using CZT Camera

Condition:   Coronary Artery Disease
Intervention:   Other: ASSESSMENT OF CORONARY FLOW RESERVE BY PET-H215O AND FFR
Sponsors:   University Hospital, Caen;   Spectrum Dynamics
Recruiting - verified July 2015

Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

Conditions:   Peripheral Arterial Disease;   Diabetic Foot
Interventions:   Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
Sponsor:   Celgene Corporation
Recruiting - verified July 2015

Metformin in Kidney Disease

Conditions:   Chronic Kidney Disease;   Cardiovascular Disease;   Metabolic Syndrome
Interventions:   Drug: metformin;   Drug: Placebo
Sponsor:   Department of Veterans Affairs
Recruiting - verified July 2015

Zilver Flex Post-Market Study in Japan

Condition:   Peripheral Arterial Disease (PAD)
Intervention:   Device: Zilver Flex Bare Metal Stent
Sponsor:   Cook
Active, not recruiting - verified July 2015

PLATINUM Diversity

Conditions:   Atherosclerosis;   Coronary Artery Disease
Intervention:   Device: Percutaneous coronary intervention (Promus PREMIER)
Sponsor:   Boston Scientific Corporation
Recruiting - verified July 2015

Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort Study

Conditions:   Psoriatic Arthritis;   Atherosclerosis;   Arterial Stiffness
Intervention:   Other: PsA MDA
Sponsor:   Chinese University of Hong Kong
Recruiting - verified July 2015

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Condition:   Hyperlipidemia
Interventions:   Drug: Evacetrapib;   Drug: Atorvastatin;   Drug: Ezetimibe;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified July 2015

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Condition:   Peripheral Artery Disease (PAD)
Interventions:   Drug: Ticagrelor;   Drug: Comparator
Sponsors:   AstraZeneca;   CPC Clinical Research
Recruiting - verified July 2015

DES Versus BiOSS LIM - POLBOS II Study

Condition:   Coronary Artery Disease
Interventions:   Procedure: Coronary angioplasty with stent implantation;   Drug: Dual antipletlet therapy (DAPT)
Sponsor:   Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Completed - verified July 2015

Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia

Condition:   Myocardial Ischemia
Intervention:  
Sponsors:   Weill Medical College of Cornell University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2015

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   The Cleveland Clinic
Recruiting - verified July 2015

DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia

Conditions:   Behavioral and Psychological Symptoms in Alzheimer's Disease;   Behavioral and Psychological Symptoms in Vascular Dementia
Interventions:   Drug: DAOIB;   Drug: Placebo
Sponsor:   Chang Gung Memorial Hospital
Recruiting - verified July 2015

Negative Pressure Wound Therapy for the Prevention of Surgical Site Infection Following Lower Limb Revascularization

Conditions:   Surgical Wound Infection;   Peripheral Vascular Diseases
Interventions:   Device: Prevena (Negative Pressure Wound Therapy Device);   Device: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing
Sponsors:   Western University, Canada;   Kinetic Concepts, Inc.
Recruiting - verified July 2015

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

Conditions:   Coronary Arteriosclerosis;   Non ST Segment Elevation Acute Coronary Syndrome
Interventions:   Device: OrbusNeich Combo stent™;   Device: Everolimus Eluting Stent (EES)
Sponsors:   OrbusNeich;   OrbusNeich Medical K.K.;   Duke Clinical Research Institute
Recruiting - verified July 2015

Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)

Condition:   Myocardial Ischemia
Interventions:   Device: Celution System;   Device: Placebo
Sponsor:   Cytori Therapeutics
Active, not recruiting - verified December 2014

A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes

Conditions:   Diabetic Nephropathies;   Coronary Artery Disease
Interventions:   Drug: Allopurinol;   Drug: Placebo
Sponsors:   Alessandro Doria;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Juvenile Diabetes Research Foundation;   Joslin Diabetes Center;   University of Minnesota - Clinical and Translational Science Institute;   University of Colorado, Denver;   University of Michigan;   University of Toronto;   Feinberg School of Medicine, Northwestern University;   Albert Einstein College of Medicine of Yeshiva University;   Steno Diabetes Center;   Washington University School of Medicine;   University of Washington;   Emory University;   University of Calgary;   University of Alberta;   University of Texas Southwestern Medical Center
Recruiting - verified May 2015

Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion

Condition:   Coronary Artery Disease
Intervention:  
Sponsors:   Saint Luke's Health System;   Boston Scientific Corporation
Active, not recruiting - verified July 2015

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: bococizumab (PF-04950615);   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified July 2015

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: bococizumab (PF-04950615);   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified July 2015

Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent

Condition:   Coronary Artery Disease
Interventions:   Device: Abbott Laboratories Xience;   Device: Biotronik Orsiro
Sponsor:   Biotronik AG
Active, not recruiting - verified July 2015

Global Study of a Drug-coated Balloon to Treat Obstructive SFA and/or Popliteal Lesions

Condition:   Peripheral Arterial Disease
Intervention:   Device: CVI Paclitaxel-Coated PTA Balloon Catheter
Sponsor:   Spectranetics Corporation
Active, not recruiting - verified July 2015

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Conditions:   Heart Failure;   Coronary Artery Disease
Interventions:   Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified July 2015

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Condition:   Coronary Artery Disease (CAD)
Interventions:   Drug: Ticagrelor;   Drug: Acetylsalicylic Acid;   Drug: Clopidogrel
Sponsors:   ECRI bv;   Biosensors International;   AstraZeneca;   The Medicines Company
Recruiting - verified July 2015

An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery

Conditions:   Coronary Artery Disease;   Angina Pectoris;   Cardiac Valve Disease
Interventions:   Device: SternaLock Blue closure system;   Device: Suture Wire
Sponsor:   Biomet, Inc.
Active, not recruiting - verified July 2015

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Condition:   Peripheral Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   AstraZeneca
Active, not recruiting - verified July 2015

Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   AUM Cardiovascular, Inc.
Recruiting - verified July 2015

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Conditions:   Psoriasis;   Vascular Inflammation;   Coronary Atherosclerosis
Interventions:   Biological: Adalimumab;   Other: Placebo
Sponsors:   Innovaderm Research Inc.;   Abbott;   Montreal Heart Institute
Active, not recruiting - verified July 2015

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Conditions:   Intermittent Claudication;   Peripheral Artery Disease
Interventions:   Biological: PLX-PAD Low dose;   Biological: PLX-PAD high doses;   Biological: Double Placebo;   Biological: high dose +Placebo
Sponsor:   Pluristem Ltd.
Recruiting - verified May 2015

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)

Conditions:   Acute Coronary Syndrome;   Angina Pectoris;   Angina, Unstable;   Myocardial Infarction;   Coronary Artery Disease;   Coronary Stenosis;   Coronary Restenosis
Interventions:   Device: Orsiro;   Device: Synergy;   Device: Resolute Integrity
Sponsor:   Cardio Research Enschede BV
Enrolling by invitation - verified July 2015

Safety and Feasibility of the Zotarolimus Stent in Treating Males With Erectile Dysfunction (ED)

Conditions:   Erectile Dysfunction;   Atherosclerosis
Intervention:   Device: Zotarolimus-Eluting Peripheral Stent System
Sponsor:   Medtronic Endovascular
Terminated - verified July 2015

Depression Care for Hospitalized Coronary Heart Disease Patients: Prospective Cohort Study

Conditions:   Coronary Heart Disease;   Depression
Intervention:  
Sponsors:   Charite University, Berlin, Germany;   University Hospital Muenster
Active, not recruiting - verified July 2015

IN.PACT Global Clinical Study

Condition:   Peripheral Arterial Disease
Intervention:   Device: IN.PACT Admiral™ Drug Eluting Balloon
Sponsor:   Medtronic Endovascular
Active, not recruiting - verified July 2015

The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2
Interventions:   Drug: Liraglutide;   Drug: Placebo
Sponsor:   Haugaard, Steen Bendix, M.D., DMSc
Completed - verified July 2015

Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)

Condition:   Saphenous Vein Graft Disease
Interventions:   Drug: Atorvastatin 80 mg daily;   Drug: Atorvastatin 10 mg daily
Sponsors:   Boca Raton Regional Hospital;   Pfizer
Recruiting - verified July 2015

Impact of Adalimumab Therapy on Brachial Endothelial Function and Large Artery Stiffness in Patients With Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis
Interventions:   Device: transthoracic echocardiographic;   Device: Doppler ultrasound.;   Biological: blood samples
Sponsor:   Assistance Publique Hopitaux De Marseille
Completed - verified September 2014

The CONFIRM Registry

Conditions:   Atherosclerosis;   Coronary Artery Disease;   Cardiovascular Disease
Intervention:  
Sponsor:   Weill Medical College of Cornell University
Enrolling by invitation - verified July 2015

Beijing Percutaneous Coronary Intervention Registry

Condition:   Coronary Heart Disease
Intervention:  
Sponsor:   Cardiovascular Institute & Fuwai Hospital
Recruiting - verified July 2015

Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Diabetic Patients With Aortocoronary Bypass

Conditions:   Coronary Artery Disease;   Left Ventricular Dysfunction;   Type 2 Diabetes Mellitus
Intervention:   Drug: Exenatide
Sponsors:   Charles University, Czech Republic;   Eli Lilly and Company
Completed - verified July 2015

Safety and Efficacy Registry of Yinyi Stent

Condition:   Coronary Artery Disease
Intervention:   Device: Yinyi stent
Sponsor:   Shanghai Jiao Tong University School of Medicine
Completed - verified October 2008

DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population

Conditions:   Acute Coronary Syndrome;   Angina Pectoris;   Angina, Unstable;   Myocardial Infarction;   Coronary Artery Disease;   Coronary Stenosis;   Coronary Restenosis
Interventions:   Device: Resolute Integrity (Zotarolimus-eluting stent);   Device: Promus Element (Everolimus-eluting stent)
Sponsor:   Cardio Research Enschede BV
Completed - verified July 2015

Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

Conditions:   Atherosclerosis;   Hypercholesterolemia
Interventions:   Drug: Statin Drugs;   Other: HMG-CoA Reductase Inhibitors
Sponsor:   National Institutes of Health Clinical Center (CC)
Active, not recruiting - verified April 2015

Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy

Conditions:   Coronary Artery Disease;   Ischemia
Intervention:  
Sponsors:   Weill Medical College of Cornell University;   Stony Brook University
Completed - verified July 2015

A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus

Condition:   Coronary Artery Disease
Interventions:   Device: DRUG ELUTING STENT;   Device: BARE METAL STENT
Sponsor:   Scitech Produtos Medicos Ltda
Completed - verified July 2015

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente

Conditions:   Coronary Artery Disease;   Angina Pectoris;   Unstable Angina Pectoris;   Coronary Stenosis;   Coronary Restenosis
Interventions:   Device: Endeavor Resolute (Biolinx-based Zotarolimus-eluting stent);   Device: Xience V (Everolimus-eluting stent)
Sponsor:   Cardio Research Enschede BV
Completed - verified July 2015

Stress Management and Biomarkers of Risk in Cardiac Rehabilitation

Condition:   Coronary Heart Disease
Interventions:   Behavioral: SMT-enhanced Cardiac Rehabilitation;   Behavioral: Standard Cardiac Rehabilitation
Sponsors:   Duke University;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified July 2015

Coronary Artery Disease Management Using Multislice Computed Tomography and Magnetic Resonance Imaging

Condition:   Coronary Artery Disease
Interventions:   Procedure: CT/MR;   Procedure: Catheterization
Sponsors:   Charite University, Berlin, Germany;   University Hospital Muenster;   Medizinische Hochschule Hannover, Eva Schönenberger, MD;   University of Freiburg
Recruiting - verified July 2015

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

Condition:   Peripheral Vascular Disease
Intervention:   Device: Complete SE Vascular Stent System
Sponsor:   Medtronic Endovascular
Completed - verified July 2015

Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death

Conditions:   Coronary Heart Disease;   Congestive Heart Failure;   Ventricular Dysfunction;   Low Cardiac Output;   Sudden Cardiac Death
Interventions:   Drug: Optimized medical therapy;   Device: Implantable Cardioverter Defibrillator
Sponsors:   St. Michael's Hospital, Toronto;   Institute for Clinical Evaluative Sciences;   Ontario Ministry of Health and Long Term Care
Terminated - verified July 2015

Coronary CT Angiography in Asymptomatic Diabetes Mellitus

Condition:   Diabetes Mellitus
Intervention:   Other: Imaging study, No intervention
Sponsors:   Carmel Medical Center;   European Foundation for the Study of Diabetes
Active, not recruiting - verified February 2015

Enhancing the Secondary Prevention of Coronary Artery Disease

Conditions:   Coronary Disease;   Ischemic Heart Disease
Intervention:   Behavioral: Evidence summaries endorsed by local opinion leaders
Sponsors:   University of Alberta;   Heart and Stroke Foundation of Canada;   Alberta Heritage Foundation for Medical Research;   Pfizer
Completed - verified July 2015

Imaging of Plaque With Magnetic Resonance Imaging (MRI)

Condition:   Arterial Occlusive Disease
Intervention:   Procedure: Intravascular MRI
Sponsors:   Brigham and Women's Hospital;   Peter Ganz MD
Completed - verified July 2015

Get CardioSmart

You're Invited